CNB
PTCT icon

City National Bank’s PTC Therapeutics PTCT Stock Holding History

City National Bank’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-61,780
Closed -$2.97M – 875
2015
Q2 		$2.97M Sell
61,780
-102,024
-62% -$5.95M 0.02% 325
2015
Q1 		$9.97M Sell
163,804
-11,975
-7% -$731K 0.08% 217
2014
Q4 		$9.1M Buy
175,779
+20,478
+13% +$901K 0.08% 220
2014
Q3 		$6.83M Buy
155,301
+8,434
+6% +$264K 0.06% 238
2014
Q2 		$3.84M Buy
146,867
+79,262
+117% +$1.7M 0.04% 294
2014
Q1 		$1.77M Buy
67,605
+33,412
+98% +$898K 0.02% 321
2013
Q4 		$580K Buy
+34,193
New +$601K 0.01% 534

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

City National Bank's PTCT Position: Q3 2015 in Review

City National Bank sold out of PTC Therapeutics (PTCT) in Q3 2015, closing a stake of 61,780 shares — an estimated $2.97M sold.

City National Bank first reported a position in PTCT in Q4 2013 and held it in 7 quarters. The position peaked at $9.97M in Q1 2015. 157 funds tracked by Wall St. Rank hold PTCT as of Q3 2015.

  • City National Bank reported no remaining PTC Therapeutics position as of Q3 2015 after selling out during the quarter.
  • City National Bank sold 61,780 PTC Therapeutics shares in Q3 2015, an estimated $2.97M.
  • City National Bank first reported a position in PTC Therapeutics in Q4 2013 and held it in 7 quarters.
  • City National Bank's PTC Therapeutics position peaked at $9.97M in Q1 2015.
  • 157 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.